PTC Therapeutics ptcbio.com


Public list: BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180) Rare Diseases (230)

PTC Therapeutics (PTC) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC has assembled technologies and extensive knowledge of post-transcriptional control processes that it applies in its drug discovery and d...Show all

PTC Therapeutics (PTC) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes ...Show all

Company (IPO / Went public)

Phone: 908-222-7000

Fax:

100 Corporate Court

South Plainfield, 07080
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PTC Therapeutics $292.3M Jun 20, 2013
CombiMatrix $56.3M Nov 15, 2017
eSionic $38.5M Feb 11, 2013
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PTC Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 40 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Substituted triazine bmi-1 inhibitors Nov 21, 2013 May 22, 2018 Patent
Compounds for treating spinal muscular atrophy Nov 14, 2016 May 15, 2018 Patent
Compounds for treating spinal muscular atrophy Mar 14, 2013 Mar 13, 2018 Patent
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Jul 07, 2017 Jan 30, 2018 Patent
Compounds for treating spinal muscular atrophy Aug 26, 2016 Jan 30, 2018 Patent
See all 110 patents